Table 2.
Patient characteristics in total and matched cohorts
| Characteristic | Total set |
Matched set |
||||||
|---|---|---|---|---|---|---|---|---|
| Non-LT patients (n = 495) | LT patients (n = 218) | SD, % | p value | Non-LT patients (n = 146) | LT patients (n = 146) | SD, % | p value | |
| Age, yr | 55.1 ± 20.6 (3–96) | 54.2 ± 12.2 (3–75) | 4.9 | 0.519 | 56.3 ± 20.4 (3–96) | 55.3 ± 11.8 (3–75) | 6.0 | 0.594 |
| Sex, male:female | 195:300 | 144:74 | 50.9 | < 0.001a | 92:54 | 87:59 | 5.54 | 0.548 |
| PD stent | 155 (31.3) | 25 (11.5) | 92.5 | < 0.001a | 24 (16.4) | 21 (14.4) | 12.1 | 0.627 |
| Rectal indomethacin | 287 (58.0) | 54 (24.8) | 80.2 | < 0.001a | 41 (28.1) | 39 (26.7) | 4.98 | 0.793 |
| PD opacification | 275 (55.6) | 104 (47.7) | 15.3 | < 0.001a | 70 (47.9) | 69 (47.3) | 1.25 | 0.907 |
| Post-ERCP pancreatitis | 16 (3.2) | 2 (0.9) | 0.069 | 7 (4.8) | 1 (0.7) | 0.067 | ||
| Mild/Mod/Severe | 14-1-1 | 1/1/0 | 0.178 | 5/1/1 | 1/0/0 | 0.188 | ||
Values are expressed as mean ± SD (range) or number (%).
LT, liver transplantation; SD, standard deviation; PD, pancreatic duct; ERCP, endoscopic retrograde cholangiopancreatography.
a
p < 0.05 between groups.